Consensus Cyclopharm Limited

Equities

CYC

AU000000CYC5

Delayed Australian S.E. Other stock markets 07:10:42 02/05/2024 BST			5-day change	1st Jan Change
1.8 ^AUD	+2.86%		+2.86%	-6.49%

03-19	Cyclopharm's Technegas Device Carries Out Imaging of First US Patients	MT
03-18	Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index	CI

Evolution of the average Target Price on Cyclopharm Limited

Price target over the last 5 years

History of analyst recommendation changes

a50b4bc656f7ce549c863.dFIc1_nYsLeixKH5iTREurjwr3zE-XEFBSp0hjyqBiw.AWRUoY7o8c3gh5ad-1MJ64-2xwSTwRtzTlAFsVjCdmghAVC9gYqG78H07A~8cc658a52397e849a19affdc8bd75418

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.177 USD

Average target price

3.004 USD

Spread / Average Target

+155.12%

High Price Target

3.519 USD

Spread / Highest target

+198.86%

Low Price Target

2.489 USD

Spread / Lowest Target

+111.39%

Consensus detail

Consensus revision (last 18 months)

Ratings for Cyclopharm Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar